(Q48870938)

16 February 2018

title

Combined intravenous pharmacotherapy in the treatment of patients with decompensated congestive heart failure (English)

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

26 October 2022

0 references

0 references

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

26 October 2022

congestive heart failure

1 reference

B. F. Uretsky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1674636

26 October 2022

J. Hua

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1674636

26 October 2022

language of work or name

English

0 references

publication date

1 June 1991

1 reference

16 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0002870391900802?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

https://api.elsevier.com/content/article/PII:0002870391900802?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

26 October 2022

published in

American Heart Journal

1 reference

16 February 2018

volume

121

1 reference

16 February 2018

issue

6 Pt 1

1 reference

16 February 2018

page(s)

1879-1886

1 reference

16 February 2018

The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients

26 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock

26 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Combined vasodilator and inotropic therapy of heart failure: experimental and clinical concepts

26 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Effect of combined nitroglycerin and dobutamine infusion in left ventricular dysfunction

26 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Hemodynamic assessment of amrinone. A new inotropic agent

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.

26 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure

26 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy

26 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure

26 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Myocardial energetics and efficiency in patients with idiopathic cardiomyopathy: response to dobutamine and amrinone

26 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Dopamine-1 and dopamine-2 mechanisms in the control of renal function.

26 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Diuresis and natriuresis during continuous dopamine-1 receptor stimulation

26 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Hemodynamic, renal, and neurohumoral effects of a selective oral DA1 receptor agonist (fenoldopam) in patients with congestive heart failure.

26 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-8703(91)90080-2

26 October 2022

Identifiers

1 reference

16 February 2018

release_u2ugnhqmmzdw3jmy7a4c4jyw6q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/u2ugnhqmmzdw3jmy7a4c4jyw6q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

16 February 2018